Related Experiment Videos
[Ivermectin use in tropical medicine].
J Dupouy-Camet1, H Yera, C Tourte-Schaefer
1Service de parasitologie-mycologie, CHU Cochin, AP-HP, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France. jean.dupouy-camet@cch.ap-hop-paris.fr
Summary
Ivermectin is a breakthrough drug for treating parasitic infections like onchocerciasis and scabies. While generally safe, its use in young children and pregnant women requires further study.
Area of Science:
- Parasitology
- Pharmacology
- Genetics
Context:
- Ivermectin is a crucial antiparasitic medication.
- Effective against onchocerciasis, strongyloidiasis, scabies, and cutaneous larva migrans.
- Combination therapy with albendazole enhances efficacy for lymphatic filariasis and intestinal worms.
Purpose:
- To review the efficacy and safety of ivermectin.
- To discuss its application in various parasitic infections.
- To highlight areas for future research, including its use in children, pregnancy, and pediculosis.
Summary:
- Ivermectin demonstrates significant therapeutic value in treating a range of helminthic and ectoparasitic infections.
- Its safety profile is favorable, though specific populations like children under five and pregnant individuals warrant careful consideration.
- Potential links between ivermectin tolerance and mdr1 gene expression suggest a genetic component.
Impact:
- Ivermectin represents a major advancement in managing debilitating parasitic diseases globally.
- Understanding its safety in vulnerable groups and exploring new applications like pediculosis can broaden its therapeutic impact.
- Further research into genetic factors influencing tolerance may optimize treatment strategies.